BIT 5.00% 1.9¢ biotron limited

$30 Billion Deal, page-4284

  1. 14,030 Posts.
    lightbulb Created with Sketch. 2392
    As posted to @Thaliat.

    Never assume that you are the only one with knowledge. That is sort of arrogant and is not a good lookEnthusiasm is one thing but ignoring common sense will always end in tears.

    Biotron expects to have data from three such
    trials available in the very near term which puts
    the Company in a very strong position.
    These
    data, if positive, will be central to successfully
    negotiating and completing a commercial
    transaction for the Company’s HIV‐1 and
    COVID‐19 clinical programs.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.